ACRIGEN BIOSCIENCES
Acrigen Biosciences is dedicated to making gene editing safe. It develops technologies to improve efficiency and enhance the safety of CRISPR-Cas based gene editing. CRISPR-Cas system which enables the precise enzymatic editing of genes is one of the most exciting and promising techniques to be developed in the last few years with the capability to prevent or cure many devastating diseases. It was founded in 2019 and is headquartered in Berkeley, California.
ACRIGEN BIOSCIENCES
Industry:
Biotechnology Genetics Life Science
Founded:
2019-01-01
Address:
Berkeley, California, United States
Country:
United States
Website Url:
http://www.acrigen.com
Total Employee:
1+
Status:
Active
Total Funding:
1.23 M USD
Technology used in webpage:
Euro Squarespace Hosted
Similar Organizations
Abogen Biosciences
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based RNA and DNA therapeutics.
Alga Biosciences
Alga Biosciences is eliminating enteric methane emissions at scale.
Bayspair
Genome ediitng servise
Blacksmith Medicines
Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology.
GeneMind Biosciences
GeneMind Biosciences is a domestic third-generation single-molecule gene sequencing system.
Mane Biotech
Unlocking the body's regeneration potential to grow hair.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Advisors List
Current Employees Featured
Founder
Investors List
National Science Foundation
National Science Foundation investment in Grant - Acrigen Biosciences
Alexandria Venture Investments
Alexandria Venture Investments investment in Seed Round - Acrigen Biosciences
Red Tree Venture Capital
Red Tree Venture Capital investment in Seed Round - Acrigen Biosciences
Berkeley Catalyst Fund (BCF)
Berkeley Catalyst Fund (BCF) investment in Seed Round - Acrigen Biosciences
Dolby Family Ventures
Dolby Family Ventures investment in Seed Round - Acrigen Biosciences
National Science Foundation
National Science Foundation investment in Grant - Acrigen Biosciences
Official Site Inspections
http://www.acrigen.com Semrush global rank: 9.03 M Semrush visits lastest month: 445
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Acrigen Biosciences"
Acrigen Biosciences - Crunchbase Company Profile & Funding
Acrigen Biosciences is dedicated to making gene editing safe. It develops technologies to improve efficiency and enhance the safety of CRISPR-Cas based gene editing. CRISPR-Cas system …See details»
Acrigen Biosciences Inc. : r/recruitinghell - Reddit
Acrigen Biosciences Inc. I've been on a search for a WAH job since we bow have a newborn, paternity leave is almost up and the whole time of pregnancy and afterbirth, I've been applying …See details»
Acrigen Biosciences Company Profile 2024: Valuation, Funding ...
Acrigen Biosciences has raised $4M. Who are Acrigen Biosciences’s investors? Alexandria Venture Investments , Dolby Family Ventures , Red Tree Venture Capital , National Institutes …See details»
Acrigen Biosciences - Overview, News & Similar companies
Sep 27, 2021 Who is Acrigen Biosciences. Acrigen Biosciences is an early-stage life science gene editing company based in Berkeley, California. We are building a pipeline of therapies to …See details»
Acrigen Biosciences - LinkedIn
Acrigen Biosciences is an early-stage life science gene editing company based in Berkeley, California. We are building a pipeline of therapies to treat genetic disorders using our …See details»
Acrigen Biosciences - Contacts, Employees, Board Members
Organization. Acrigen Biosciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Acrigen Biosciences has 1 …See details»
Working at Acrigen Biosciences - Zippia
Learn about working at Acrigen Biosciences from employee reviews and detailed data on culture, salaries, demographics, management, financial, and more. ... Organization Type. Private. …See details»
Acrigen Biosciences - VentureRadar
At Acrigen, we believe that gene editing will revolutionize medicine and bring hope to millions of patients suffering from genetic diseases. We are developing anti-CRISPR (Acr) technology to …See details»
Acrigen Biosciences - Products, Competitors, Financials, Employees ...
Acrigen Biosciences Raises Seed Financing to Advance Precision Gene Editing Technology and Therapeutic Pipeline. Sep 28, 2021. 09/28/2021 | 10:33am EDT Message : *Required fields …See details»
Acrigen Biosciences - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Feb 24, 2022: Grant - Acrigen …See details»
Acrigen Biosciences - Berkeley Startup Cluster
Acrigen Biosciences. BioTech. Developer of gene technologies designed to improve the efficiency and enhance the safety of CRISPR-Cas-based gene editing. The company’s technologies …See details»
Company: Acrigen Biosciences - crisprmedicinenews.com
Nov 22, 2024 Acrigen Biosciences develops novel high precision gene-editing systems. The company seeks to identify and develop next-generation CRISPR-Cas nucleases using its …See details»
Our Technology — Acrigen Biosciences
Acrigen has developed a novel method to solve the ‘off-target’ editing problem. Editing at unintended sites in the genome is a serious risk for any CRISPR therapy. To eliminate editing …See details»
Acrigen Biosciences, Inc. | Intellectual Property & Industry …
Acrigen’s proprietary technology leverages novel αCas and μCas CRISPR gene editors coupled with ErAcrs (engineered anti-CRISPR proteins) to create an editing toolbox with best-in-class …See details»
Acrigen Biosciences Raises Seed Financing to Advance Precision …
Sep 28, 2021 Acrigen Biosciences is an early-stage life science gene editing company based in Berkeley, California. We are building a pipeline of therapies to treat genetic disorders using …See details»
Acrigen Biosciences Raises Seed Financing to Advance Precision …
Sep 28, 2021 Acrigen was established with a core team from the leading gene editing laboratories at the University of California Berkeley. The company recently expanded its …See details»
David Rabuka - Founder, CEO, President @ Acrigen Biosciences ...
Primary Organization . Acrigen Biosciences . Location Saskatchewan, Canada, North America; ... President at Acrigen Biosciences. Additionally, David Rabuka has had 3 past jobs including …See details»
Acrigen Biosciences Raises Seed Financing to Advance ... - BioSpace
Sep 28, 2021 Acrigen Biosciences is an early-stage life science gene editing company based in Berkeley, California. We are building a pipeline of therapies to treat genetic disorders using …See details»
Publications — Acrigen Biosciences
Original Acrigen Publications. New Results. Discovery and engineering of AiEvo2, a novel Cas12a nuclease for human gene editing applications. Allison Sharrar, Luisa Arake de Tacca, Zuriah …See details»